CUV 1.80% $14.12 clinuvel pharmaceuticals limited

Ann: Positive Final Results in Stroke Study CUV801, page-25

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,043 Posts.
    lightbulb Created with Sketch. 673
    Yes, all that data exists, but none of it was presented to show how the improvement in outcomes fared in comparison to historical data. But keep in mind, such data is global and to make a valid comparison you need to know recovery trajectory under similar hospital/ward conditions as the patients in the study - it would only be behind-closed-doors discussions with the treating medical experts who have an expert clinical feel for this with CUV to give them an indication if it looks positive to go ahead with the next step. Certainly doesn't seem to do any harm, but I strongly disagree that this study showed any efficacy unless they present comparison data of a similar matched group of patients from medical records at the same hospital. I want this to succeed and move to the next step, only CUV have been misleading in their release using the word efficacy without backing up the claim.
    Last edited by Fernit: 06/05/22
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.